Business Wire

QIAGEN and DiaSorin widen access to latent TB testing in the U.S. with FDA approval of ...

HILDEN, Germany & SALUGGIA, Italy--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and DiaSorin (FTSE MIB: DIA) today announced that the U.S. Food and Drug Administration (FDA) has ...
Nasdaq

QIAGEN, in partnership with DiaSorin, announces the launch of the new LIAISON® LymeDetect ...

The LIAISON® LymeDetect® assay is a solution for the early diagnosis of Lyme Borreliosis combining detection of IgG and IgM Antibodies and cellular immunity The test is available in countries ...
生物通

LIAISON?军团菌尿抗原检测方法的临床评估（对其诊断性能的考量）

Legionella尿液抗原检测LIAISON?试验性能评估显示其特异性100%、敏感性97%，与现有CE认证方法等效，证实该化学发光免疫分析法 ...
Pharmabiz

US FDA approves Qiagen’s QuantiFERON-TB Gold Plus assay for use on DiaSorin’s automated ...

Qiagen and DiaSorin announced that the US Food and Drug Administration (FDA) has approved the Liaison QuantiFERON-TB Gold Plus assay for use on DiaSorin’s automated Liaison XS platform. The approval ...
Nasdaq

QIAGEN Says FDA Approves QuantiFERON-TB Gold Plus Assay On LIAISON XS Platform

(RTTNews) - QIAGEN (QGEN) and DiaSorin said Monday that the U.S. Food and Drug Administration has approved the LIAISON QuantiFERON-TB Gold Plus assay for use on DiaSorin's automated LIAISON XS ...
Business Wire

QIAGEN, in partnership with DiaSorin, announces the launch of the new LIAISON® LymeDetect ...

HILDEN, Germany & SALUGGIA, Italy--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and DiaSorin (FTSE MIB: DIA) today announced the launch of the LIAISON ® LymeDetect ® Assay ...